Recent research from the University of Arizona Health Sciences has uncovered a promising new alternative for managing pain—terpenes derived from the Cannabis sativa plant. According to a study published in Pharmacological Reports, these natural compounds could offer relief for conditions such as fibromyalgia and post-surgical pain, potentially reducing the reliance on opioids.
Terpenes and Their Role in Pain Management
Earlier investigations led by Dr. John Streicher, a key researcher at the Comprehensive Center for Pain & Addiction, demonstrated the potential of terpenes in alleviating pain linked to inflammation and chemotherapy-induced nerve damage. Building upon that work, this latest study explored their impact on chronic pain conditions, providing fresh insights into their effectiveness.
A Focus on Chronic Pain Relief
While terpenes do not appear to be effective for acute pain—such as that caused by minor injuries or burns—their impact on persistent pain conditions has been significant. “Our research indicates that terpenes may not be the best choice for sudden injuries like a stubbed toe or a burn, but they show remarkable promise in managing long-term, pathological pain,” said Streicher, a professor in the Department of Pharmacology at the University of Arizona’s College of Medicine in Tucson.
This study marked the first attempt to evaluate terpenes in preclinical models of fibromyalgia and post-surgical pain. Its findings suggest that these compounds could broaden the spectrum of non-opioid pain management options.
Read more: The Reason Smoking Weed Affects You Differently As You Age
Nature’s Pain Relievers: The Four Key Terpenes
The research team focused on four specific terpenes found in moderate to high levels in Cannabis sativa:
- Geraniol
- Linalool
- Beta-caryophyllene
- Alpha-humulene
All four demonstrated significant pain relief in laboratory models. Geraniol showed the strongest pain-reducing effects, followed by linalool, beta-caryophyllene, and alpha-humulene.
- Geraniol – Found in various essential oils such as rose and citronella, geraniol has been shown to have anti-inflammatory and neuroprotective properties. In this study, it exhibited the most substantial pain-relieving effects, making it a promising candidate for future therapeutic applications.
- Linalool – This terpene is commonly associated with lavender and is known for its calming, sedative properties. It has been widely researched for its potential in reducing anxiety and stress, but in this study, it also demonstrated notable pain relief effects, particularly in fibromyalgia models.
- Beta-caryophyllene – Unique among terpenes, beta-caryophyllene can interact directly with CB2 receptors in the body’s endocannabinoid system. Found in black pepper, cloves, and cannabis, it has been shown to reduce inflammation and neuropathic pain without inducing psychoactive effects.
- Alpha-humulene – Present in hops, sage, and ginger, alpha-humulene has been recognized for its anti-inflammatory and analgesic properties. While it exhibited the least potent pain relief among the four terpenes studied, its ability to modulate inflammation still makes it a valuable component in natural pain management.
These findings highlight the potential of terpenes as non-opioid alternatives for pain relief, particularly in chronic conditions where conventional medications may fall short.
Read more: Vaping vs. Smoking: Groundbreaking Study Suggests E-Cigarettes May Be Even More Harmful
A New Approach to Fibromyalgia Treatment
Fibromyalgia remains a complex and poorly understood condition, affecting up to 5% of the global population. According to a 2023 study published in Healthcare (Basel), approximately 4 million adults in the U.S. live with this chronic musculoskeletal disorder. Women are more frequently affected than men, and treatment options remain limited.
“Fibromyalgia is difficult to manage because we still don’t fully understand its pain mechanisms,” Streicher noted. “Our findings suggest that terpenes could be a promising new treatment for fibromyalgia pain, potentially offering relief to many who currently struggle with inadequate options.”
Addressing Post-Surgical Pain
Pain following surgery often exists in a gray area between acute and chronic pain. While temporary, post-surgical pain can trigger physiological responses such as heightened inflammation and increased sensitivity to pain.
Opioids have long been the standard treatment for post-operative pain, but their side effects—such as constipation and the risk of dependency—raise concerns. “Opioids are effective for managing pain after surgery, but they can cause digestive issues that might lead to post-surgical complications, like adhesions,” Streicher explained. “We’re always searching for safer alternatives, and this study suggests that terpenes might offer a new therapeutic option.”
Globally, an estimated 310 million major surgeries take place each year, according to a 2020 report published in the International Journal of Surgery. A safer, non-opioid alternative for post-surgical pain management could benefit millions of patients worldwide.
Unlocking Nature’s Potential for Medicine
Dr. Todd Vanderah, director of the Comprehensive Center for Pain & Addiction at the University of Arizona Health Sciences, emphasized the broader significance of this research. “The work being conducted in Dr. Streicher’s lab highlights the importance of basic research. Plants, including Cannabis, produce hundreds of unique chemical compounds, many of which remain undiscovered,” Vanderah said.
“Nature has a remarkable ability to generate complex chemical structures, some of which may hold the key to treating human diseases and disorders. A great example is semaglutide, sold as Ozempic, which was derived from a peptide found in the venom of the Gila monster. Research like this has the potential to uncover groundbreaking treatments from natural sources.”
Read more: 8 Cancer Killing Foods Most People Don’t Think Twice About
How Terpenes Work: A Connection to Caffeine?
The study also explored how terpenes exert their pain-relieving effects. Findings suggest that their mechanism of action involves the adenosine A2a receptor—a target also influenced by caffeine. This receptor is known for its role in sedation, which could offer further avenues for research into terpenes’ potential benefits.
The study, titled “Select terpenes from Cannabis sativa are antinociceptive in mouse models of post-operative pain and fibromyalgia via adenosine A2a receptors,” was authored by Caleb A. Seekins, Alyssa M. Welborn, Abigail M. Schwarz, and John M. Streicher. It was published on December 12, 2024, in Pharmacological Reports (DOI: 10.1007/s43440-024-00687-1).
Future Research and Implications
The promising results of this study pave the way for further investigations into terpene-based treatments. With opioid addiction and dependency remaining major public health challenges, the need for alternative pain management solutions has never been more urgent.
As researchers continue to unlock the potential of plant-based compounds, terpenes may become a key player in the future of pain relief. While much work remains, these findings offer hope for millions suffering from chronic pain conditions.
